People living with gMG around the world continue to experience severe disease burden despite treatment with commonly-used therapies.
Tag:
Biotechnology
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on the…
Atai Life Sciences, a psychedelics-focused biotech leverages a decentralized platform approach to accelerate the development of more effective mental health treatments. The clinical-stage biopharmaceutical company aims to transform the treatment…
Essa Pharma is a clinical-stage biotechnology company focused on the development of novel therapies for the treatment of prostate and other hormone-driven cancers. The company was founded with technology licensed…
Molecular Templates is a clinical-stage biopharmaceutical company focused on developing targeted biologic therapeutics for treatment of oncology. Molecular’s proprietary drug platform technology, called engineered toxin bodies (ETBs), represents a next…
Wave Life Sciences is a biotechnology company focused on delivering transformational therapies for patients with serious and genetically-defined diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using…
Cidara Therapeutics is a biotechnology company developing long-acting therapeutics for patients facing serious fungal or viral infections. The company’s portfolio is comprised of its lead antifungal candidate, Rezafungin, in addition…
Ionis Pharmaceuticals announced that the biotechnology company has launched a new grant program that provides funding to researchers whose work advances the understanding of transthyretin amyloidosis (ATTR), facilitates early diagnosis…
- 1
- 2